搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Desulforudis audaxviator Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP532929DJM
CSB-EP532929DJM
CSB-BP532929DJM
CSB-MP532929DJM
CSB-EP532929DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Maf-like protein Daud_1468 (Daud_1468) CSB-YP532930DJM
CSB-EP532930DJM
CSB-BP532930DJM
CSB-MP532930DJM
CSB-EP532930DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP532931DJM
CSB-EP532931DJM
CSB-BP532931DJM
CSB-MP532931DJM
CSB-EP532931DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP532932DJM
CSB-EP532932DJM
CSB-BP532932DJM
CSB-MP532932DJM
CSB-EP532932DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Heat-inducible transcription repressor HrcA (hrcA) CSB-YP532933DJM
CSB-EP532933DJM
CSB-BP532933DJM
CSB-MP532933DJM
CSB-EP532933DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Probable transaldolase (tal) CSB-YP532934DJM
CSB-EP532934DJM
CSB-BP532934DJM
CSB-MP532934DJM
CSB-EP532934DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L9 (rplI) CSB-YP532935DJM
CSB-EP532935DJM
CSB-BP532935DJM
CSB-MP532935DJM
CSB-EP532935DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 30S ribosomal protein S18 (rpsR) CSB-YP532936DJM
CSB-EP532936DJM
CSB-BP532936DJM
CSB-MP532936DJM
CSB-EP532936DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Threonine--tRNA ligase (thrS), partial CSB-YP532937FNA
CSB-EP532937FNA
CSB-BP532937FNA
CSB-MP532937FNA
CSB-EP532937FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Recombination protein RecR (recR) CSB-YP532938FNA
CSB-EP532938FNA
CSB-BP532938FNA
CSB-MP532938FNA
CSB-EP532938FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Transcriptional repressor NrdR (nrdR) CSB-YP532939FNA
CSB-EP532939FNA
CSB-BP532939FNA
CSB-MP532939FNA
CSB-EP532939FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ribonuclease Y (rny), partial CSB-YP532940FNA
CSB-EP532940FNA
CSB-BP532940FNA
CSB-MP532940FNA
CSB-EP532940FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0348 protein SPH_1851 (SPH_1851) CSB-YP532941FNA
CSB-EP532941FNA
CSB-BP532941FNA
CSB-MP532941FNA
CSB-EP532941FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Indole-3-glycerol phosphate synthase (trpC) CSB-YP532942FNA
CSB-EP532942FNA
CSB-BP532942FNA
CSB-MP532942FNA
CSB-EP532942FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP532943FNA
CSB-EP532943FNA
CSB-BP532943FNA
CSB-MP532943FNA
CSB-EP532943FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Segregation and condensation protein A (scpA) CSB-YP532944FNA
CSB-EP532944FNA
CSB-BP532944FNA
CSB-MP532944FNA
CSB-EP532944FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP532945FNA
CSB-EP532945FNA
CSB-BP532945FNA
CSB-MP532945FNA
CSB-EP532945FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S10 (rpsJ) CSB-YP532946FNA
CSB-EP532946FNA
CSB-BP532946FNA
CSB-MP532946FNA
CSB-EP532946FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L29 (rpmC) CSB-YP532947FNA
CSB-EP532947FNA
CSB-BP532947FNA
CSB-MP532947FNA
CSB-EP532947FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L30 (rpmD) CSB-YP532948FNA
CSB-EP532948FNA
CSB-BP532948FNA
CSB-MP532948FNA
CSB-EP532948FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>